Skip to main content
. Author manuscript; available in PMC: 2012 Sep 8.
Published in final edited form as: J Med Chem. 2011 Aug 5;54(17):6014–6027. doi: 10.1021/jm200454y

Table 5.

Effect of MDR-1 Inhibition on the Potency of Antitubulin Drugs toward Renal Carcinoma Cell Line 786-0

conditions drug IC50 (nM) against 786-0 cells
paclitaxel vincristine vinblastine 8
drug alone 31 37 4.5 0.58
drug + verapamil 4.0 1.2 0.31 0.39